UK: A Numbers Game? – Infringement Of Numerical Claims Following Actavis v Eli Lilly

Last Updated: 2 July 2019
Article by Michael Ford

A recently reported case in the High Court of England and Wales has shed further light on how patent claims are being interpreted in the UK following the 2017 landmark decision of the Supreme Court in Actavis v Eli Lilly.

In Regen Lab SA v Estar Medical Ltd & Ors, claimant Regen was the proprietor of European patent EP2073862 with claims covering a method for the preparation of blood plasma enriched in platelets and other factors (known as platelet rich plasma or PRP). Regen accused various respondents of infringement of the patent by supplying kits in the UK which were subsequently used to prepare PRP according to the claimed method. The defendants counterclaimed for revocation of the patent.

Although the patent was ultimately found to be invalid for lack of novelty and inventive step, Judge Hacon expressed an opinion that, if the patent had been found valid, it would have been infringed. In his decision, Judge Hacon discussed the application of the doctrine of equivalents, introduced by Actavis v Eli Lilly, to the interpretation of numerical values in claims.

By way of background, prior to Actavis v Eli Lilly, the practice of the UK courts was to determine patent infringement on the basis of a purposive construction of the claims as they would have been read by a person skilled in the art. Infringement was found if the product or process fell within the scope of the claims on the basis of this construction.

Following the Actavis decision, however, the test for infringement is now divided into two steps. The first step involves determining whether the alleged infringement falls within the scope of the claims on the basis of normal interpretation. If the alleged infringement does fall within the scope of the claims on that basis, infringement is proven and the assessment stops. However, if the alleged infringement does not fall within the scope of the claims on the basis of normal interpretation, it is now necessary to assess whether the so-called variant nevertheless infringes because it differs from the claimed invention in only an immaterial way. This is referred to as applying the doctrine of equivalents. Actavis v Eli Lilly set out a series of questions to be considered when applying this doctrine. In the Actavis case, application of the doctrine led to the finding that pemetrexed dipotassium was equivalent to pemetrexed disodium as claimed.

Returning to Regen Lab v Estar Medical, the claim in question required centrifuging blood in a separator tube containing a polyester-based thixotropic gel and a buffered sodium citrate solution at 0.10 M. The defendants' process made use of a thixotropic gel which contained Tris (2-ethylhexyl) trimellitate and a buffered sodium citrate solution at 0.136 M. It was found that there would be no infringement on the basis of a normal interpretation of the claims, as Tris (2-ethylhexyl) trimellitate is not a polyester and 0.136 M is considered to be sufficiently different from 0.10 M, as would be expected when considering the number of decimal places or significant figures usually taken into account in the interpretation of numerical claim limitations.

However, following Actavis, the Court went on to assess whether infringement could nevertheless be proved on the basis of the doctrine of equivalents. In this assessment, Judge Hacon had to consider two key points: first, how the doctrine should be applied when there are multiple differences between the alleged infringement and the claim; and second, whether the doctrine applies to numerical values. The defendants, in particular, had argued that the doctrine should not apply in relation to a numerical claim.

In respect of the first issue, Judge Hacon concluded that the key question is whether the accused product or process is a variant falling within the scope of the claim taking all equivalents into account. Although it may be convenient to consider each equivalent one by one, there must be a single overall answer in relation to each accused product or process.

In respect of the second issue, the Court concluded that the approach to claims containing one or more numerical limits should be no different to that applicable to any other type of claim, and that principle was not changed by the decision in Actavis v Eli Lilly. Furthermore, Judge Hacon stated that to require strict compliance with a numerical limitation in a claim would put numerical claims into a special class, as strict compliance is not necessarily required of any other type of claim limitation.

Judge Hacon then went on to conclude that the inventive concept of the patent claim is exploited in substantially the same way as to achieve substantially the same result if the process uses a non-polymeric thixotropic gel and the sodium citrate buffer solution has a molarity of 0.136 M instead of 0.10 M. This fact would have been obvious to the skilled person at the priority date. Further, Judge Hacon thought that the molarity of the solution in particular was not essential to the inventive concept, such that strict compliance with the literal meaning of the claim would not have been intended. Accordingly, it was found that the respondents would have infringed the patent based on the doctrine of equivalents, had the patent been valid.

This case highlights the potentially far-reaching effects of the Actavis decision. Last year in Icescape v Ice- World, the Court of Appeal also found, by applying the Actavis doctrine, that a series arrangement of manifolds in a mobile ice rink would infringe a claim explicitly reciting a parallel arrangement. These decisions suggest that the UK's lower courts will continue to apply the doctrine of equivalents to all claim features, including chemical species, the arrangement of mechanical components, and numerical limitations, at least until further guidance from a higher court is received.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions